loading

Menu

Read More

00 days
00 : 00
00 sec

Delivering novel antibiotics to combat life threatening bacterial infections.


Subscribe

About Us

logo

tackling drug-resistant bacterial infections

Zolex Therapeutics Ltd is a recently established drug company focusing on the development of new classes of orally-active, small molecular weight antibiotics that target Staphylococcus aureus (Staph. A), including Methicillin Resistant Staphylococcus aureus (MRSA) strains.

Zolex Therapeutics is located within the RadBioMed Accelerator at Ramat Hachayal, Tel-Aviv and is led by Dr. Lewis Neville (CSO) and Dr. Ziv Lifshitz (Senior Scientist).

Subscribe

Subscribe to our newsletter to get our latest news

Please enter your email:

Contact

  • Find us on

Write to us

Need help or just want to send us a message?